Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence-Reference-Cited by-同舟云学术

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence

Published:2004 Issue:2 Volume:113 Page:259-266
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Smith Caroline L.,Dunbar P. Rod,Mirza Fareed,Palmowski Michael J.,Shepherd Dawn,Gilbert Sarah C.,Coulie Pierre,Schneider Joerg,Hoffman Eric,Hawkins Robert,Harris Adrian L.,Cerundolo Vincenzo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

2. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

3. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers

4. In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells

5. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA and modified vaccinia Ankara prime–boost vaccination generates strong CD8 + T cell responses against minor histocompatibility antigen HA‐1;British Journal of Haematology;2021-05-28

2. COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform;Vaccines;2021-02-18

3. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression;Journal for ImmunoTherapy of Cancer;2021-02

4. Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse;OncoImmunology;2020-01-01

5. Modified Vaccinia Virus Ankara Can Induce Optimal CD8 + T Cell Responses to Directly Primed Antigens Depending on Vaccine Design;Journal of Virology;2019-11